Summit, Wellcome Trust enter revenue sharing agreement for ridinilazole

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) and the Wellcome Trust (London, U.K.) entered into an equity and revenue sharing agreement that covers future revenues

Read the full 231 word article

User Sign In